MRNA Moderna
Nasdaq · SEC CIK 1682852 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $64.63M 14 sales by 6 insiders
- Filings on record
- 574 since 2021-07-02, latest 2026-09-16 16:48
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Bancel Stephane | CEO, Dir | — | $28.72M |
| Hoge Stephen | Pres | — | $28.43M |
| Mock James M | CFO | — | $4.69M |
| Klinger Shannon Thyme | CLO | — | $1.39M |
| AFEYAN NOUBAR | Dir | — | $1.14M |
| Hussain Abbas | Dir | — | $278.9K |
| Horning Sandra | Dir | — | — |
| NABEL ELIZABETH G | Dir | — | — |
| Rubenstein David M. | Dir | — | — |
| Nader Francois | Dir | — | — |
Transactions 1,002
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-10-06 | 2025-10-03 | MRNA | Mock James M | CFO | F - Tax | $28.37 | -703 | 18.3K | -4% | -$19.9K |
| D | 2025-10-06 | 2025-10-03 | MRNA | Mock James M | CFO | M - OptEx | — | +1,453 | 19.0K | +8% | — |
| D | 2025-10-06 | 2025-10-02 | MRNA | Hussain Abbas | Dir | M - OptEx | — | +1,439 | 2,019 | +248% | — |
| D | 2025-09-02 | 2025-08-29 | MRNA | Klinger Shannon Thyme | CLO | F - Tax | $24.47 | -113 | 28.2K | -0.4% | -$2,765 |
| D | 2025-09-02 | 2025-08-29 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | — | +232 | 28.3K | +0.8% | — |
| D | 2025-09-02 | 2025-08-29 | MRNA | Hoge Stephen | Pres | M - OptEx | — | +651 | 1.45M | +0.0% | — |
| D | 2025-09-02 | 2025-08-29 | MRNA | Hoge Stephen | Pres | F - Tax | $24.47 | -315 | 1.45M | -0.0% | -$7,708 |
| DM | 2025-08-29 | 2025-08-27+ | MRNA | Klinger Shannon Thyme | CLO | F - Tax | $24.84 | -535 | 27.9K | -2% | -$13.3K |
| DM | 2025-08-29 | 2025-08-27+ | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | — | +1,103 | 28.2K | +4% | — |
| DM | 2025-08-29 | 2025-08-27+ | MRNA | Mock James M | CFO | M - OptEx | — | +1,103 | 17.7K | +7% | — |
| DM | 2025-08-29 | 2025-08-27+ | MRNA | Mock James M | CFO | F - Tax | $24.84 | -535 | 17.5K | -3% | -$13.3K |
| DM | 2025-08-29 | 2025-08-27+ | MRNA | Hoge Stephen | Pres | M - OptEx | — | +2,048 | 1.45M | +0.1% | — |
| DM | 2025-08-29 | 2025-08-27+ | MRNA | Hoge Stephen | Pres | F - Tax | $24.84 | -991 | 1.45M | -0.1% | -$24.6K |
| D | 2025-08-06 | 2025-08-05 | MRNA | Rubenstein David M. | Dir | M - OptEx | — | +850 | 1,527 | +126% | — |
| D | 2025-07-07 | 2025-07-03 | MRNA | Mock James M | CFO | M - OptEx | — | +1,453 | 17.6K | +9% | — |
| D | 2025-07-07 | 2025-07-03 | MRNA | Mock James M | CFO | F - Tax | $30.28 | -703 | 16.9K | -4% | -$21.3K |
| 2025-06-12 | 2025-06-11 | MRNA | Hussain Abbas | Dir | S - Sale | $28.00 | -312 | 580 | -35% | -$8,736 | |
| D | 2025-06-09 | 2025-06-06 | MRNA | Klinger Shannon Thyme | CLO | F - Tax | $26.12 | -551 | 27.5K | -2% | -$14.4K |
| D | 2025-06-09 | 2025-06-06 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | — | +1,139 | 28.0K | +4% | — |
| D | 2025-06-02 | 2025-05-30 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | — | +233 | 26.4K | +0.9% | — |
| D | 2025-06-02 | 2025-05-30 | MRNA | Klinger Shannon Thyme | CLO | F - Tax | $26.93 | -113 | 26.3K | -0.4% | -$3,043 |
| D | 2025-06-02 | 2025-05-30 | MRNA | Hoge Stephen | Pres | M - OptEx | — | +652 | 1.45M | +0.0% | — |
| D | 2025-06-02 | 2025-05-30 | MRNA | Hoge Stephen | Pres | F - Tax | $26.93 | -316 | 1.45M | -0.0% | -$8,510 |
| DM | 2025-05-29 | 2025-05-27+ | MRNA | Hoge Stephen | Pres | F - Tax | $26.41 | -990 | 1.45M | -0.1% | -$26.1K |
| DM | 2025-05-29 | 2025-05-27+ | MRNA | Hoge Stephen | Pres | M - OptEx | — | +2,046 | 1.45M | +0.1% | — |
| DM | 2025-05-29 | 2025-05-27+ | MRNA | Mock James M | CFO | F - Tax | $26.41 | -533 | 16.2K | -3% | -$14.1K |
| DM | 2025-05-29 | 2025-05-27+ | MRNA | Mock James M | CFO | M - OptEx | — | +1,101 | 16.4K | +7% | — |
| DM | 2025-05-29 | 2025-05-27+ | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | — | +1,101 | 26.3K | +4% | — |
| DM | 2025-05-29 | 2025-05-27+ | MRNA | Klinger Shannon Thyme | CLO | F - Tax | $26.41 | -533 | 26.0K | -2% | -$14.1K |
| D | 2025-05-01 | 2025-04-30 | MRNA | Horning Sandra | Dir | M - OptEx | — | +979 | 2,352 | +71% | — |
| D | 2025-05-01 | 2025-04-30 | MRNA | Hussain Abbas | Dir | M - OptEx | — | +892 | 892 | New | — |
| D | 2025-05-01 | 2025-04-30 | MRNA | NABEL ELIZABETH G | Dir | M - OptEx | — | +979 | 3,084 | +47% | — |
| D | 2025-05-01 | 2025-04-30 | MRNA | Rubenstein David M. | Dir | M - OptEx | — | +677 | 677 | New | — |
| D | 2025-04-07 | 2025-04-04 | MRNA | Mock James M | CFO | M - OptEx | — | +1,452 | 16.3K | +10% | — |
| D | 2025-04-07 | 2025-04-04 | MRNA | Mock James M | CFO | F - Tax | $25.73 | -703 | 15.6K | -4% | -$18.1K |
| D | 2025-03-10 | 2025-03-07 | MRNA | Klinger Shannon Thyme | CLO | F - Tax | $34.30 | -551 | 25.6K | -2% | -$18.9K |
| D | 2025-03-10 | 2025-03-07 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | — | +1,139 | 26.2K | +5% | — |
| MI | 2025-03-04 | 2025-03-03 | MRNA | Bancel Stephane | CEO, Dir | P - Purchase | $31.22 | +160.3K | 9.21M | +2% | +$5.00M |
| I | 2025-03-04 | 2025-03-03 | MRNA | SAGAN PAUL | Dir | P - Purchase | $31.76 | +31.6K | 312.0K | +11% | +$1.00M |
| DM | 2025-03-03 | 2025-02-28 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | — | +562 | 25.2K | +2% | — |
| DM | 2025-03-03 | 2025-02-28 | MRNA | Klinger Shannon Thyme | CLO | F - Tax | $31.09 | -273 | 25.0K | -1% | -$8,488 |
| D | 2025-03-03 | 2025-02-28 | MRNA | Mock James M | CFO | M - OptEx | — | +329 | 15.0K | +2% | — |
| D | 2025-03-03 | 2025-02-28 | MRNA | Mock James M | CFO | F - Tax | $31.09 | -160 | 14.9K | -1% | -$4,974 |
| DM | 2025-03-03 | 2025-02-28 | MRNA | Hoge Stephen | Pres | F - Tax | $31.09 | -612 | 1.45M | -0.0% | -$19.0K |
| DM | 2025-03-03 | 2025-02-28 | MRNA | Hoge Stephen | Pres | M - OptEx | — | +1,263 | 1.45M | +0.1% | — |
| DM | 2025-02-28 | 2025-02-27 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | — | +5,747 | 24.9K | +30% | — |
| DM | 2025-02-28 | 2025-02-27 | MRNA | Klinger Shannon Thyme | CLO | F - Tax | $33.58 | -2,779 | 24.7K | -10% | -$93.3K |
| DM | 2025-02-28 | 2025-02-27 | MRNA | Mock James M | CFO | F - Tax | $33.58 | -2,780 | 12.4K | -18% | -$93.4K |
| DM | 2025-02-28 | 2025-02-27 | MRNA | Mock James M | CFO | M - OptEx | — | +5,746 | 13.1K | +79% | — |
| D | 2025-02-28 | 2025-02-27 | MRNA | Hoge Stephen | Pres | F - Tax | $33.58 | -2,779 | 1.45M | -0.2% | -$93.3K |
| D | 2025-02-28 | 2025-02-27 | MRNA | Hoge Stephen | Pres | M - OptEx | — | +5,746 | 1.45M | +0.4% | — |
| 2025-02-14 | 2025-02-12 | MRNA | Hoge Stephen | Pres | A - Grant | $0.00 | +5,734 | 1.45M | +0.4% | $0 | |
| 2025-02-14 | 2025-02-12 | MRNA | Hoge Stephen | Pres | F - Tax | $30.93 | -2,771 | 1.45M | -0.2% | -$85.7K | |
| 2025-02-14 | 2025-02-12 | MRNA | Klinger Shannon Thyme | CLO | A - Grant | $0.00 | +2,047 | 22.5K | +10% | $0 | |
| 2025-02-14 | 2025-02-12 | MRNA | Klinger Shannon Thyme | CLO | F - Tax | $30.93 | -1,068 | 21.4K | -5% | -$33.0K | |
| 2025-02-14 | 2025-02-12 | MRNA | Bancel Stephane | CEO, Dir | F - Tax | $30.93 | -6,400 | 5.49M | -0.1% | -$198.0K | |
| 2025-02-14 | 2025-02-12 | MRNA | Bancel Stephane | CEO, Dir | A - Grant | $0.00 | +13.2K | 5.50M | +0.2% | $0 | |
| D | 2025-02-10 | 2025-02-07 | MRNA | Hoge Stephen | Pres | F - Tax | $33.61 | -281 | 1.44M | -0.0% | -$9,444 |
| D | 2025-02-10 | 2025-02-07 | MRNA | Hoge Stephen | Pres | M - OptEx | — | +523 | 1.44M | +0.0% | — |
| D | 2025-01-06 | 2025-01-03 | MRNA | Mock James M | CFO | M - OptEx | — | +1,453 | 12.5K | +13% | — |
| D | 2025-01-06 | 2025-01-03 | MRNA | Mock James M | CFO | F - Tax | $42.00 | -780 | 11.7K | -6% | -$32.8K |
| D | 2024-12-10 | 2024-12-09 | MRNA | Klinger Shannon Thyme | CLO | S - Sale+OE | $44.68 | -529 | 20.4K | -3% | -$23.6K |
| D | 2024-12-10 | 2024-12-06 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | — | +1,138 | 21.0K | +6% | — |
| D | 2024-12-04 | 2024-12-02 | MRNA | Hoge Stephen | Pres | M - OptEx | — | +651 | 1.44M | +0.0% | — |
| D | 2024-12-04 | 2024-12-03 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $43.30 | -314 | 1.44M | -0.0% | -$13.6K |
| D | 2024-12-04 | 2024-12-03 | MRNA | Klinger Shannon Thyme | CLO | S - Sale+OE | $43.30 | -112 | 19.8K | -0.6% | -$4,850 |
| D | 2024-12-04 | 2024-12-02 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | — | +232 | 19.9K | +1% | — |
| D | 2024-12-02 | 2024-11-29 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $42.79 | -291 | 1.44M | -0.0% | -$12.5K |
| D | 2024-12-02 | 2024-11-27 | MRNA | Hoge Stephen | Pres | M - OptEx | — | +610 | 1.44M | +0.0% | — |
| DM | 2024-12-02 | 2024-11-27 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | — | +2,981 | 18.5K | +19% | — |
| D | 2024-12-02 | 2024-11-29 | MRNA | Klinger Shannon Thyme | CLO | S - Sale+OE | $42.79 | -1,418 | 19.7K | -7% | -$60.7K |
| DM | 2024-12-02 | 2024-11-27 | MRNA | Mock James M | CFO | M - OptEx | — | +2,981 | 12.5K | +31% | — |
| D | 2024-12-02 | 2024-11-29 | MRNA | Mock James M | CFO | S - Sale+OE | $42.79 | -1,420 | 11.1K | -11% | -$60.8K |
| D | 2024-11-12 | 2024-11-08 | MRNA | Hoge Stephen | Pres | M - OptEx | — | +523 | 1.44M | +0.0% | — |
| D | 2024-11-12 | 2024-11-11 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $46.10 | -277 | 1.44M | -0.0% | -$12.8K |
| D | 2024-10-08 | 2024-10-07 | MRNA | Mock James M | CFO | S - Sale+OE | $60.12 | -715 | 9,505 | -7% | -$43.0K |
| D | 2024-10-08 | 2024-10-04 | MRNA | Mock James M | CFO | M - OptEx | — | +1,453 | 10.2K | +17% | — |
| D | 2024-09-10 | 2024-09-09 | MRNA | Klinger Shannon Thyme | CLO | S - Sale+OE | $73.57 | -551 | 18.2K | -3% | -$40.5K |
| D | 2024-09-10 | 2024-09-06 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | — | +1,139 | 18.7K | +6% | — |
| D | 2024-09-04 | 2024-09-03 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $76.99 | -318 | 1.44M | -0.0% | -$24.5K |
| D | 2024-09-04 | 2024-08-30 | MRNA | Hoge Stephen | Pres | M - OptEx | — | +652 | 1.44M | +0.0% | — |
| D | 2024-09-04 | 2024-09-03 | MRNA | Klinger Shannon Thyme | CLO | S - Sale+OE | $76.99 | -114 | 17.6K | -0.6% | -$8,777 |
| D | 2024-09-04 | 2024-08-30 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | — | +233 | 17.7K | +1% | — |
| D | 2024-08-30 | 2024-08-28 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | — | +329 | 17.6K | +2% | — |
| D | 2024-08-30 | 2024-08-29 | MRNA | Klinger Shannon Thyme | CLO | S - Sale+OE | $78.03 | -162 | 17.4K | -0.9% | -$12.6K |
| D | 2024-08-30 | 2024-08-29 | MRNA | Mock James M | CFO | S - Sale+OE | $78.03 | -162 | 8,767 | -2% | -$12.6K |
| D | 2024-08-30 | 2024-08-28 | MRNA | Mock James M | CFO | M - OptEx | — | +329 | 8,929 | +4% | — |
| D | 2024-08-30 | 2024-08-29 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $78.03 | -300 | 1.44M | -0.0% | -$23.4K |
| D | 2024-08-30 | 2024-08-28 | MRNA | Hoge Stephen | Pres | M - OptEx | — | +611 | 1.44M | +0.0% | — |
| D | 2024-08-29 | 2024-08-27 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | — | +2,652 | 18.6K | +17% | — |
| D | 2024-08-29 | 2024-08-28 | MRNA | Klinger Shannon Thyme | CLO | S - Sale+OE | $79.39 | -1,319 | 17.3K | -7% | -$104.7K |
| DM | 2024-08-29 | 2024-08-27 | MRNA | Mock James M | CFO | M - OptEx | — | +2,652 | 9,921 | +36% | — |
| D | 2024-08-29 | 2024-08-28 | MRNA | Mock James M | CFO | S - Sale+OE | $79.39 | -1,321 | 8,600 | -13% | -$104.9K |
| D | 2024-08-13 | 2024-08-12 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $84.10 | -254 | 1.44M | -0.0% | -$21.4K |
| D | 2024-08-13 | 2024-08-09 | MRNA | Hoge Stephen | Pres | M - OptEx | — | +522 | 1.44M | +0.0% | — |
| MT | 2024-08-02 | 2024-07-31 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $119.96 | -15.0K | 2.22M | -0.7% | -$1.80M |
| MT | 2024-07-26 | 2024-07-24 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $117.80 | -15.0K | 2.25M | -0.7% | -$1.77M |
| MT | 2024-07-19 | 2024-07-17 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $122.84 | -15.0K | 2.27M | -0.7% | -$1.84M |
| 2024-07-16 | 2024-07-15 | MRNA | Hoge Stephen | Pres | S - Sale | $121.12 | -15.0K | 1.44M | -1% | -$1.82M | |
| MT | 2024-07-12 | 2024-07-10 | MRNA | AFEYAN NOUBAR | Dir | S - Sale | $117.08 | -15.0K | 2.27M | -0.7% | -$1.76M |
Purchase Sale Sale after option exercise All abbreviations